trastuzumab deruxtecan
roche,zymeworks,daiichi sankyo,jazz,astrazeneca
['enhertu', '$dsnky', '$zyme', '$azn', '$jazz', 'jazz', '$rhhby']
$azn $dsnky $jazz $rhhby $zyme asco 2023 enhertu hits with pan approach 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities